Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis
Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis is a paper indexed in ScholarIQ from OpenAlex.
How many citations does Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis have?
Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis has 48 citations in the OpenAlex counts ScholarIQ stores.
When was Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis published?
Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis has 2017 year in the ScholarIQ index.
What is the open-access status of Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis?
Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis has diamond oa status in the ScholarIQ index.
What is the DOI of Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis?
The DOI for Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis is on the source record.
What is the PMID of Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis?
The PMID for Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis is on the source record.
What is the OpenAlex record for Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis?
The OpenAlex for Anti-MDA5 antibody as a potential diagnostic and prognostic biomarker in patients with dermatomyositis is on the source record.